Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

763.00p
   
  • Change Today:
    -13.00p
  • 52 Week High: 853.00
  • 52 Week Low: 400.00
  • Currency: UK Pounds
  • Shares Issued: 82.05m
  • Volume: 48,278
  • Market Cap: £626.02m
  • RiskGrade: 289

Latest ShareCast News

Oxford Biomedica signs deal with UK-backed vaccine group

By Sean Farrell

Date: Monday 08 Jun 2020

(Sharecast News) - Oxford Biomedica has signed a deal with a UK government-backed vaccine group to increase manufacturing capacity for AstraZeneca's Covid-19 vaccine.

Oxford Biomedica swings to loss as licensing revenue falls

By Josh White

Date: Wednesday 06 May 2020

(Sharecast News) - Gene and cell therapy company Oxford Biomedica reported an improvement in bioprocessing and commercial development revenues to ?47.3m in its preliminary results on Wednesday, from ?40.5m.

Liberum hikes target price on Oxford Biomedica

By Iain Gilbert

Date: Tuesday 28 Apr 2020

(Sharecast News) - Analysts at Liberum hiked their target price on gene and cell therapy company Oxford BioMedica from £8.60 per share to £10.90 on Tuesday, citing demand at its new OxBox manufacturing facility.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 763.00p
Change Today -13.00p
% Change -1.68 %
52 Week High 853.00
52 Week Low 400.00
Volume 48,278
Shares Issued 82.05m
Market Cap £626.02m
RiskGrade 289

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.01% below the market average31.01% below the market average31.01% below the market average31.01% below the market average31.01% below the market average
7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average
Price Trend
57.55% above the market average57.55% above the market average57.55% above the market average57.55% above the market average57.55% above the market average
22.81% above the sector average22.81% above the sector average22.81% above the sector average22.81% above the sector average22.81% above the sector average
Income Not Available
Growth
16.27% above the market average16.27% above the market average16.27% above the market average16.27% above the market average16.27% above the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 07-Jul-2020

Time Volume / Share Price
15:18 431 @ 763.48p
15:10 3 @ 765.95p
15:05 2 @ 763.46p
15:01 32 @ 763.00p
15:01 74 @ 763.00p

OXB Key Personnel

CEO John Dawson
CFO Stuart Paynter

Top of Page